Topics

Biofrontera AG: Correction of a release from 03/02/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

11:37 EST 3 Feb 2020 | EQS Group

Biofrontera AG
03.02.2020 / 16:37
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: Biofrontera AG
Street: Hemmelrather Weg 201
Postal code: 51377
City: Leverkusen
Germany
Legal Entity Identifier (LEI): 391200D6GFSVFGFQTL13

2. Reason for notification
Acquisition/disposal of shares with voting rights
Acquisition/disposal of instruments
Change of breakdown of voting rights
X Other reason:
Voluntary group notification due to threshold approach of a subsidiary (please also note item 10)

3. Details of person subject to the notification obligation
Natural person (first name, surname): Wilhelm K. T. Zours
Date of birth: 28 Jul 1961

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
DELPHI Unternehmensberatung Aktiengesellschaft, SPARTA AG, Deutsche Balaton Biotech AG

5. Date on which threshold was crossed or reached:
28 Jan 2020

6. Total positions
% of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 29.88 % 0.06 % 29.94 % 44849365
Previous notification 29.72 % 0.00 % 29.72 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE0006046113 0 13400957 % 29.88 %
Total 13400957 29.88 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
%
Total %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Bearer Bond Cash 26500 0.06 %
Total 26500 0.06 %

8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
Strawtec Group AG % % %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
ABC Beteiligungen AG 29.87 % % 29.87 %
Heidelberger Beteiligungsholding AG 29.87 % % 29.87 %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
SPARTA AG 29.87 % % 29.87 %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
Prisma Equity AG 29.87 % % 29.87 %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
Deutsche Balaton Biotech AG 29.87 % % 29.93 %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
MARNA Beteiligungen AG % % %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
Altech Advanced Materials AG % % %
Wilhelm K. T. Zours % % %
DELPHI Unternehmensberatung Aktiengesellschaft 29.87 % % 29.87 %
VV Beteiligungen Aktiengesellschaft % % %
Deutsche Balaton Aktiengesellschaft 29.87 % % 29.87 %
Ming Le Sports AG % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
Delphi Unternehmensberatung Aktiengesellschaft, Deutsche Balaton Aktiengesellschaft, SPARTA AG, Deutsche Balaton Biotech AG, Prisma Equity AG, ABC Beteiligungen AG and Heidelberger Beteiligungsholding signed a voting pool agreement on January 28, 2020. The purpose of this agreement is to combine the interests of the pool members in order to secure joint influence on the company, in particular through the joint voting of the Biofrontera shares covered by this agreement for all resolutions and elections of Biofronteras' shareholders' meeting. The parties under the Pool Agreement currently include the following holdings in Biofrontera: DELPHI Unternehmensberatung Aktiengesellschaft - 14.65% SPARTA AG - 7.17% Deutsche Balaton Biotech AG - 4.46% Deutsche Balaton Aktiengesellschaft - 2.96% Prisma Equity AG - 0.40% ABC Beteiligungen AG - 0.23% Heidelberg Beteiligungsholding AG - 0.0022% 

Date
31 Jan 2020



03.02.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Original Article: Biofrontera AG: Correction of a release from 03/02/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

NEXT ARTICLE

More From BioPortfolio on "Biofrontera AG: Correction of a release from 03/02/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...